CABENUVA Drug Patent Profile
✉ Email this page to a colleague
When do Cabenuva patents expire, and what generic alternatives are available?
Cabenuva is a drug marketed by Viiv Hlthcare and is included in one NDA. There are eight patents protecting this drug.
The generic ingredient in CABENUVA is cabotegravir; rilpivirine. One supplier is listed for this compound. Additional details are available on the cabotegravir; rilpivirine profile page.
DrugPatentWatch® Generic Entry Outlook for Cabenuva
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CABENUVA?
- What are the global sales for CABENUVA?
- What is Average Wholesale Price for CABENUVA?
Summary for CABENUVA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for CABENUVA |
| What excipients (inactive ingredients) are in CABENUVA? | CABENUVA excipients list |
| DailyMed Link: | CABENUVA at DailyMed |
US Patents and Regulatory Information for CABENUVA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212888-001 | Jan 21, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212888-002 | Jan 21, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Viiv Hlthcare | CABENUVA KIT | cabotegravir; rilpivirine | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212888-001 | Jan 21, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
